The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Stage

Acquired Unit | Acquired

About ZON Re - Treaty MGA

ZON Re - Treaty MGA is a US-based treaty reinsurance managing underwriter and Lloyd's coverholder.

ZON Re - Treaty MGA Headquarter Location

400 Valley Road Suite 205

Mount Arlington, New Jersey, 07856,

United States

203-446-8050

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

ZON Re - Treaty MGA Patents

ZON Re - Treaty MGA has filed 43 patents.

The 3 most popular patent topics include:

  • Photovoltaics
  • Applications of photovoltaics
  • Energy conversion
patents chart

Application Date

Grant Date

Title

Related Topics

Status

5/14/2019

9/15/2020

Photovoltaics, Energy conversion, Computer buses, USB, Serial buses

Grant

Application Date

5/14/2019

Grant Date

9/15/2020

Title

Related Topics

Photovoltaics, Energy conversion, Computer buses, USB, Serial buses

Status

Grant

  • Where is ZON Re - Treaty MGA's headquarters?

    ZON Re - Treaty MGA's headquarters is located at 400 Valley Road, Mount Arlington.

  • What is ZON Re - Treaty MGA's latest funding round?

    ZON Re - Treaty MGA's latest funding round is Acquired Unit.

  • Who are the investors of ZON Re - Treaty MGA?

    Investors of ZON Re - Treaty MGA include Nexus Group.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.